| Exports | API manufacturing and supply across multiple therapeutic areas to international pharmaceutical companies. | Regulatory approvals, manufacturing scale, first-to-market products, and strong R&D capabilities. | B2B serving multinational and regional pharmaceutical manufacturers. | High-value specialty APIs in anti-diabetic and anti-retroviral categories. | 54281 | 69 | Product sales to global regulated markets. | Contractual and volume-based pricing agreements. | Growing demand in regulated markets, expanding API portfolio, and enhanced capacity. | |
| Domestic | API manufacturing for Indian pharmaceutical companies with a diversified product portfolio. | Strong domestic manufacturing presence and regulatory compliance. | B2B serving Indian pharma firms. | High-value APIs with less price sensitivity. | 23994 | 31 | Sales to domestic pharma sector. | Direct sales with negotiated pricing. | Increasing healthcare demand and backward integration benefits. | |
